Leukocyte count and incidence of subarachnoid haemorrhage: A prospective cohort study

BMC Neurology

Volumn 14, Issue 1, 2014, Pages

  Söderholm, Martin ^a   Zia, Elisabet ^a   Hedblad, Bo ^a   Engström, Gunnar ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Epidemiology; Inflammation; Leukocytes; Subarachnoid haemorrhage

Indexed keywords

ALCOHOL; CHOLESTEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MIDDLE AGED; PATHOGENESIS; PHYSICAL INACTIVITY; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SMOKING; SUBARACHNOID HEMORRHAGE; SYSTEMIC LOW GRADE INFLAMMATION; SYSTOLIC BLOOD PRESSURE; BLOOD; COMPLICATION;

ADULT; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INFLAMMATION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE;

EID: 84898036870     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-14-71     Document Type: Article

References (28)

1. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009, 8(4):355-369. 10.1016/S1474-4422(09)70025-0, 19233729.
2. Nieuwkamp DJ, Setz LE, Algra A, Linn FH, De Rooij NK, Rinkel GJ. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 2009, 8(7):635-642. 10.1016/S1474-4422(09)70126-7, 19501022.
3. Ronkainen A, Hernesniemi J. Subarachnoid haemorrhage of unknown aetiology. Acta Neurochir (Wien) 1992, 119(1-4):29-34.
4. Van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: diagnosis, causes and management. Brain 2001, 124(Pt 2):249-278.
5. Feigin VL, Rinkel GJ, Lawes CM, Algra A, Bennett DA, Van Gijn J, Anderson CS. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke 2005, 36(12):2773-2780. 10.1161/01.STR.0000190838.02954.e8, 16282541.
6. Frösen J, Tulamo R, Paetau A, Laaksamo E, Korja M, Laakso A, Niemilä M, Hernesniemi J. Saccular intracranial aneurysm: pathology and mechanisms. Acta Neuropathol 2012, 123(6):773-786. 10.1007/s00401-011-0939-3, 22249619.
7. Lee CD, Folsom AR, Nieto FJ, Chambless LE, Shahar E, Wolfe DA. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: atherosclerosis risk in communities study. Am J Epidemiol 2001, 154(8):758-764. 10.1093/aje/154.8.758, 11590089.
8. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010, 375(9709):132-140. 3162187, 20031199.
9. Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, Wilson AC, Folsom AR, Wu K, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Haverkate F, De Maat MP, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi R, Vahtera E, Jousilahti P, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005, 294(14):1799-1809.
10. Sato S, Iso H, Noda H, Kitamura A, Imano H, Kiyama M, Ohira T, Okada T, Yao M, Tanigawa T, Yamagishi K, Nakamura M, Naito Y, Shimamoto T. Plasma fibrinogen concentrations and risk of stroke and its subtypes among Japanese men and women. Stroke 2006, 37(10):2488-2492. 10.1161/01.STR.0000242473.13884.8e, 16946147.
11. Elkind MS, Sciacca RR, Boden-Albala B, Rundek T, Paik MC, Sacco RL. Relative elevation in baseline leukocyte count predicts first cerebral infarction. Neurology 2005, 64(12):2121-2125. 10.1212/01.WNL.0000165989.12122.49, 15985584.
12. Zia E, Melander O, Björkbacka H, Hedblad B, Engström G. Total and differential leucocyte counts in relation to incidence of stroke subtypes and mortality: a prospective cohort study. J Intern Med 2012, 272(3):298-304. 10.1111/j.1365-2796.2012.02526.x, 22303818.
13. Licata G, Tuttolomondo A, Corrao S, Di Raimondo D, Fernandez P, Caruso C, Avellone G, Pinto A. Immunoinflammatory activation during the acute phase of lacunar and non-lacunar ischemic stroke: association with time of onset and diabetic state. Int J Immunopathol Pharmacol 2006, 19(3):639-646.
14. Tuttolomondo A, Pinto A, Corrao S, Di Raimondo D, Fernandez P, Di Sciacca R, Arnao V, Licata G. Immuno-inflammatory and thrombotic/fibrinolytic variables associated with acute ischemic stroke diagnosis. Atherosclerosis 2009, 203(2):503-508. 10.1016/j.atherosclerosis.2008.06.030, 18715563.
15. Chei CL, Yamagishi K, Kitamura A, Kiyama M, Imano H, Ohira T, Cui R, Tanigawa T, Sankai T, Ishikawa Y, Sato S, Iso H. C-reactive protein levels and risk of stroke and its subtype in Japanese: The Circulatory Risk in Communities Study (CIRCS). Atherosclerosis 2011, 217(1):187-193. 10.1016/j.atherosclerosis.2011.03.001, 21444086.
16. Berglund G, Nilsson P, Eriksson KF, Nilsson JA, Hedblad B, Kristenson H, Lindgärde F. Long-term outcome of the Malmö preventive project: mortality and cardiovascular morbidity. J Intern Med 2000, 247(1):19-29. 10.1046/j.1365-2796.2000.00568.x, 10672127.
17. Kristenson H, Trell E. Indicators of alcohol consumption: comparisons between a questionnaire (Mm-MAST), interviews and serum gamma-glutamyl transferase (GGT) in a health survey of middle-aged males. Br J Addict 1982, 77(3):297-304. 10.1111/j.1360-0443.1982.tb02459.x, 6128016.
18. Söderholm M, Zia E, Hedblad B, Engström G. Lung function as a risk factor for subarachnoid hemorrhage: a prospective cohort study. Stroke 2012, 43(10):2598-2603. 10.1161/STROKEAHA.112.658427, 22871680.
19. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO. External review and validation of the Swedish national inpatient register. BMC Public Health 2011, 11:450. 10.1186/1471-2458-11-450, 3142234, 21658213.
20. Engström G, Melander O, Hedblad B. Leukocyte count and incidence of hospitalizations due to heart failure. Circ Heart Fail 2009, 2(3):217-222. 10.1161/CIRCHEARTFAILURE.108.827071, 19808343.
21. McColgan P, Thant KZ, Sharma P. The genetics of sporadic ruptured and unruptured intracranial aneurysms: a genetic meta-analysis of 8 genes and 13 polymorphisms in approximately 20,000 individuals. J Neurosurg 2010, 112(4):714-721. 10.3171/2009.8.JNS092, 19780647.
22. Baizabal Carvallo JF, Cantu Brito C, Estanol B, Garcia Ramos GS. Subarachnoid hemorrhage as a complication of systemic lupus erythematosus. Cerebrovasc Dis 2007, 24(2-3):301-304.
23. Fogelholm R, Murros K. Cigarette smoking and subarachnoid haemorrhage: a population-based case-control study. J Neurol Neurosurg Psychiatry 1987, 50(1):78-80. 10.1136/jnnp.50.1.78, 1033253, 3819759.
24. Kosierkiewicz TA, Factor SM, Dickson DW. Immunocytochemical studies of atherosclerotic lesions of cerebral berry aneurysms. J Neuropathol Exp Neurol 1994, 53(4):399-406. 10.1097/00005072-199407000-00012, 8021714.
25. Sebastian-Gambaro MA, Liron-Hernandez FJ, Fuentes-Arderiu X. Intra- and inter-individual biological variability data bank. Eur J Clin Chem Clin Biochem 1997, 35(11):845-852.
26. Pankow JS, Folsom AR, Cushman M, Borecki IB, Hopkins PN, Eckfeldt JH, Tracy RP. Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis 2001, 154(3):681-689. 10.1016/S0021-9150(00)00586-4, 11257270.
27. Rothman K, Greenland S, Lash T. Validity in Epidemiological studies. Modern Epidemiology 2008, 139-142. Philadelphia, USA: Lippincott Williams & Wilkins, 3.
28. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998, 279(18):1477-1482. 10.1001/jama.279.18.1477, 9600484.